Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis J7Z

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History J7Z

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – EUR
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth J7Z

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin J7Z

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income J7Z

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM J7Z

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio J7Z

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Jazz Pharmaceuticals plc J7Z

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself J7Z

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 8.97
Enterprise Value Revenue 3.45
Price Sales TTM 2.23
Enterprise Value EBITDA 78.28
Price Book MRQ 2.79

Jazz Pharmaceuticals plc Dividends: – Yield, History, Payment Schedule

J7Z
Current price
142.80 EUR -0.45 EUR (-0.31%)
Last closed 143.25 EUR
ISIN IE00B4Q5ZN47
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 9 190 029 917 EUR
Yield for 12 month +23.05 %
1Y
3Y
5Y
10Y
15Y
J7Z
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+3 492 969 783 EUR

Last Year

+3 291 453 253 EUR

Current Quarter

+966 700 924 EUR

Last Quarter

+897 686 238 EUR

Current Year

+3 110 349 686 EUR

Last Year

+2 917 534 355 EUR

Current Quarter

+856 064 532 EUR

Last Quarter

+797 876 555 EUR
EBITDA 1 592 128 756 EUR
Operating Margin TTM 22.33 %
Price to Earnings
Return On Assets TTM 4.88 %
PEG Ratio 7.86
Return On Equity TTM -9.06 %
Wall Street Target Price 178.99 EUR
Revenue TTM 4 116 692 174 EUR
Book Value 64.54 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6.70 %
Dividend Yield
Gross Profit TTM 3 786 647 549 EUR
Earnings per share -5.26 EUR
Diluted Eps TTM -5.26 EUR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 19.30 %
Profit Margin -8.86 %

Technical Indicators J7Z

For 52 Weeks

85.35 EUR 155.20 EUR
50 Day MA 115.40 EUR
Shares Short Prior Month
200 Day MA 106.62 EUR
Short Ratio
Shares Short
Short Percent